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INTRODUCTION
Calcifications within primary tumors can be seen in thy-
roid, breast, and ovarian neoplasms. They are also described
within benign lesions of the gastrointestinal tract, such as
leiomyomas and angiomas, or in metastases from colonic
carcinoma. However, calcifications within primary gastric
cancer are a rare finding (1, 2). Moreover, gastric uptake of
bone seeking agents in a patient with advanced gastric can-
cer is an even rare entity.
Tc-99m 3,3-diphosphono-1,2-propanedicarboxylic acid
(DPD) bone scintigraphy is used primarily for skeletal imag-
ing to detect abnormalities of the bone. However, a variety
of soft tissue abnormalities can also be detected on bone scin-
tigraphy through accumulation of bone seeking agents. Neo-
plastic, hormonal, inflammatory, ischemic, traumatic, excre-
tory, and artifactual entities demonstrate abnormal soft-tis-
sue uptake of Tc-99m DPD (3).
Recently, we experienced a case of bone scintigraphy that
demonstrated diffusely increased gastric uptake of Tc-99m
DPD in a patient with advanced gastric cancer. We report
this case along with a review of the literatures.
CASE REPORT
A 69 yr-old male patient was admitted to our hospital due
to epigastric discomfort for 2 months duration. Epigastric
discomfort was exacerbated after meals. An upper GI endos-
copy revealed a huge ulcerative creator on the posterior wall
of the prepyloric area with creamy exudates and a biopsy diag-
nosed the lesion to be adenocarcinoma. Non-contrast enhanced
computed tomography (CT) of the abdomen showed a mass
involving the lower body and antrum of the stomach with
diffuse and circumferential wall thickening, punctate calci-
fications within the gastric walls, and several lymphadeno-
pathies along the retropancreatic area (Fig. 1). Laboratory stud-
ies revealed normochromic and normocytic anemia (hemo-
globin of 10.3 g/dL, normal; 12-16 g/dL), but other labora-
tory findings including serum calcium (normal; 8.4-10.2 mg/
dL) and phosphorus (normal; 2.5-4.5 mg/dL) concentrations
were normal.
To evaluate the extent of the disease, 3 hr after injection of
20 mCi (740 MBq) of Tc-99m DPD, bone scintigraphy and
single photon emission computed tomography (SPECT) were
performed using a dual-head gamma camera (Vertex; ADAC
laboratories, Milpitas, CA, U.S.A.). Bone scintigraphy showed
gastric uptake but no evidence of bone metastasis (Fig. 2).
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Gastric Accumulation of Bone Seeking Agent in a Patient with
Advanced Gastric Cancer
Soft tissue uptake of Tc-99m labeled bone seeking agents, such as Tc-99m 3,3-
diphosphono-1,2-propanedicarboxylic acid (DPD), is commonly seen in clinical prac-
tice, even though bone scintigraphy is mainly used to detect bone disease. How-
ever, gastric uptake of bone agents in patients with gastric cancer is very rare. And
it has been reported that calcified gastric adenocarcinoma appears in only about 5%
of all gastric cancer. We report a rare case of bone scintigraphy, single photon emis-
sion computed tomography and computed tomography fusion images that demon-
strated diffuse gastric uptake of Tc-99m DPD in a patient with advanced gastric
cancer. 
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The gastric uptake was thought to be calcified tumoral up-
take. To confirm this, fusion images were constructed by com-
bining morphologic CT and functional SPECT images on a
computer workstation. The SPECT and CT fusion images
show the intense Tc-99m DPD uptake to be located in the
anterior and posterior wall of the gastric antrum (Fig. 3). 
DISCUSSION
The first report of calcified gastric cancer was by Gruber
in 1913 (4), and subsequently several other cases were reported
(5, 6). When histology was considered, most of these tumors
were proved to be mucinous adenocarcinomas. It has been
reported that mucinous gastric adenocarcinoma compromise
about 5% of all gastric cancers (7). To explain the presence
of calcifications, ‘‘dystrophic’’ and ‘‘metastatic’’ mechanisms
have been proposed (8). Dystrophic calcifications develop in
necrotic tissues, probably because denatured proteins prefer-
entially bind phosphate ions, which react with calcium ions
to form a precipitate of calcium phosphate. In these cases
plasma levels of calcium are within normal range. Metastat-
ic calcifications are simple mineral deposits in undamaged
normal tissues caused by persistent hypercalcemia. In our
case, normal level of serum calcium and phosphorus concen-
trations suggests the presence of dystrophic calcification.
Tc-99m DPD bone scintigraphy is used primarily for skele-
tal imaging to detect abnormalities of the bone. However,
bone scintigraphy also delineates a wide spectrum of non-
osseous disorders. Neoplastic, hormonal, inflammatory, ische-
mic, traumatic, excretory, and artifactual entities demonstrate
abnormal soft-tissue uptake of Tc-99m DPD. Mechanisms
leading to increased extraosseous Tc-99m DPD uptake include
extracellular fluid expansion, enhanced regional vascularity
and permeability, and elevated tissue calcium concentration.
Bone scintigraphy can show gastric uptake in various con-
ditions, including artifact due to Tc-99m-pertechnetate in
radiopharmaceutical preparation, hypercalcemia due to me-
tastatic calcinosis, dialysis patients and gastric carcinoma. In
our case, because the thyroid was not visible, visualization
of the stomach on the bone scintigraphy cannot be attribut-
ed to a faulty preparation containing free Tc-99m-pertech-
netate (9).
Fig. 1. Non-contrast enhanced CT of the upper abdomen shows
diffuse thickening of gastric antral wall with punctate calcifica-
tions (arrows).
Fig. 2. Bone scintigraphy shows increased uptake of tracer in the
gastric wall (arrow) but no evidence of bone metastasis. 
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Fig. 3. The single photon emission computed tomography (SPE-
CT) and CT fusion images show that intense Tc-99m DPD uptake
is located in the anterior and posterior wall of the gastric antrum.
However, the extent of tracer uptake is diffuse and broader than
the gross calcifications seen on CT images.
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There are a few cases showing gastric uptake of tracer in
advanced gastric cancer patients (10). However, the fact that
the extent of tracer uptake is more diffuse and broader than
that of gross calcifications seen on CT images makes our case
unique. This may suggest the presence of micro-calcifications
in the gastric wall which is not seen on CT images but is
detected in bone scintigraphy.
In summary, we describe a rare case showing gastric uptake
of Tc-99m DPD in an advanced gastric cancer patient. The
extent of tracer uptake in the gastric walls was more diffuse
and broader than that of gross calcifications seen on CT ima-
ges. Calcified gastric cancer is rare, but it was possible to detect
even micro-calcifications with Tc-99m DPD bone scintig-
raphy. As exemplified by this case, recognition of extra-skele-
tal Tc-99m DPD uptake may enhance the diagnostic value
of bone scintigraphy.
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